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A B S T R A C T
Purpose: The present study aimed to assess the impact of the ketogenic diet on arterial morphology and
endothelial function of the big vessels of the neck and on cardiac diastolic function, in a cohort of
epileptic children and young adults treated with the ketogenic diet.
Methods: Patients were recruited based on the following inclusion criteria: (1) patients who were or had
been on the ketogenic diet for a time period of at least six months. Each patient underwent measurement
of carotid intima media thickness, carotid artery stiffness, echocardiography, and diastolic function
assessment. Patients with drug resistant epilepsy, matched for number, age and sex and never treated
with ketogenic diet, were recruited as controls.
Results: The population study was composed by 43 epilepsy patients (23 males), aged between 19
months and 31 years (mean 11 years). Twenty-three patients were or had been treated with ketogenic
diet, and 20 had never been on it (control group). Subjects treated with the ketogenic diet had higher
arterial stiffness parameters, including AIx and b-index and higher serum levels of cholesterol or
triglycerides compared to those who had never been on the diet (control group) (p < 0.001).
Conclusions: Arterial stiffness is increased in children and young adults treated with the ketogenic diet,
before the increase of the intima media thickness. This supports that arterial stiffness is an early marker
of vascular damage.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The ketogenic diet for the treatment of drug resistant epilepsy is
composed of a high amount of lipids, an adequate intake of
proteins and a very low percentage of carbohydrates.1 It is well
recognized that the ketogenic diet frequently leads to a wide range
of adverse side effects, both early within the ﬁrst days and late by
the end of the ﬁrst month and on.2,3
Among early and/or late adverse effects there is dyslipidemia,
consisting of increased triglycerides and/or cholesterol,3,4 which
raises major concerns regarding the potential negative effects on
macrocirculation, including the development of atheromasic
plates, abnormalities in the vascular parietal elasticity mainly in* Corresponding author. Tel.: +39 089 965014; Mobile: +39 3382747593.
E-mail address: gcoppola@unisa.it (G. Coppola).
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.12.002the heart and brain, and a disorder of intraparenchymal
microvascular resistance in the kidney.
Therefore, a relationship between the length of the ketogenic
diet and the potential development of such cardiac and vascular
adverse events, can be reasonably assumed. Studies on cardiovas-
cular adverse effects arising major concerns upon the use of the
ketogenic diet, are so far lacking. Recently, Patel et al.,5 in a
retrospective study on the long-term effects after the ketogenic
diet had been discontinued in about one hundred patients,
reported that lipids were normal at follow-up, despite most being
abnormal while on the ketogenic diet.
On the other hand, Raitakari et al.,6 found a positive relationship
between the exposure to cardiovascular risk in pediatric age
between 12 and 18 years, and an increased thickness of the intima
and media layers of arterial vessels in adult age. These authors
state indeed that exposure to cardiovascular risk factors early in
life may induce changes in arteries that contribute to the
development of atherosclerosis.vier Ltd. All rights reserved.
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diet on arterial morphology, speciﬁcally the development of
atheromasic plates, on endothelial function of the big vessels of the
neck as well as on cardiac diastolic function, in a cohort of children
and young adults who were or had been fed the ketogenic diet.
2. Methods
All patients were followed as outpatients in the Epilepsy Unit of
the Clinic of Child Neuropsychiatry of the Second University of
Naples, and were recruited in the study in a time period comprised
between January 2008 and October 2010.
Inclusion criteria were the following: (1) patients who were or
had been on a classical (fat/protein + carbohydrate ratio 4:1)
ketogenic diet for a time period of at least six months. This time
interval was considered as the minimum treatment period to
assess clinical responsiveness to the ketogenic diet. Exclusion
criteria were: (1) patients with heart failure, systemic hyperten-
sion, diabetes mellitus, thyroid or parathyroid dysfunction; (2)
poor compliance from parents/caregivers to participate in the
study or from patients to undergo all examinations as requested by
the study schedule. Patients with drug resistant epilepsy, matching
for number, age and sex and never treated with ketogenic diet,
were recruited as controls. The study protocol was approved by the
local ethics committee; written informed consent was obtained by
parents and, when possible, by patients.
Each patient underwent the following examinations on
admission: (1) a blood sample was taken to evaluate white and
red cell blood count, alanine and aspartate transaminases, gamma-
glutamyltransferase, serum calcium, sodium and potassium, urea,
serum creatinine, blood glucose, total and free acylcarnitine, total
serum proteins, serum iron, and lipid proﬁle (total cholesterol,
high-density (HDL) and low-density (LDL) lipoprotein-cholesterol
and triglycerides).
Age at study entry, length of diet treatment, number and type of
anticonvulsant drugs, blood levels of each anticonvulsant drug,
familial dyslipidemic risk factors, and maximal blood values of
lipid proﬁle throughout the diet, were the other parameters
considered in all patients.
Serum levels of total cholesterol, triglycerides and lipoprotein
fractions were considered in normal, borderline or high range,
following Daniels and Greer,7 In all subjects, anthropometric
parameters (height and weight) were measured and body mass
index (BMI) was calculated. Furthermore, each patient underwent
on admission blood pressure assessment, measurement of carotid
intima thickness (IMT), echotracking of the common carotid for the
assessment of arterial stiffness, echocardiography and diastolic
function assessment by means of standard methodology. Blood
pressure was measured after a 5-min rest in supine position, by a
digital oscillometric device (Omron model 705 IT; Omron
Corporation – Healthcare, Kyoto, Japan) validated for use in
children and adolescents. Brachial systolic blood pressure (SBP)
and diastolic blood pressure (DBP) were calculated as the mean of
three blood pressure measurements at rest. Pulse pressure (PP)
was calculated as (SBP–DBP). Subjects with abnormal blood
pressure values were consequently excluded from the study.
2.1. Measurement of carotid IMT
Measurement of carotid intima media thickness (IMT) and
arterial stiffness high-resolution B-mode ultrasound images (Aloka
alfa 10; Tokyo, Japan) with a 7–10 MHz linear array transducer
were used to measure IMT. Carotid arteries were examined
bilaterally in the areas of common carotid (1 cm proximal to the
carotid bulb), carotid bifurcation (1 cm proximal to the ﬂow
divider) and internal carotid artery (1 cm distal to the ﬂow divider).All measurements were determined manually on the far wall in
longitudinal and transverse planes with anterior, lateral and
posterior approaches.8 Two different readings were acquired for
each projection. From B-mode images, single video frames were
selected for IMT measurements. Intima media thickness (IMT) was
deﬁned as the distance between lumen/intima and media/
adventitia interfaces. The mean value was calculated for each
parameter. Two independent readers, who were blinded with
respect to patients’ clinical and laboratory proﬁle, made the
measurements. The inter- and intra-observer variability was
assessed for each measurement from all subjects participating
in the study. The inter-observer variability of IMT measurements,
evaluated by comparing the values obtained by two sets of scans
performed by each reader, was 0  03 mm (coefﬁcient of variation
3  59%). The intra-observer variability was 0  02 mm (coefﬁcient of
variation 2  15%).
2.2. Carotid artery stiffness
Subjects were studied after resting supine for 15 min in a
temperature-controlled environment. The stiffness parameter b
was calculated according to the formula: b = ln(Ps/Pd)/(Ds  Dd/
Dd); Ep (pressure-strain elasticity modulus): Ep = (Ps  Pd)/
[(Ds  Dd)/Dd]; AC (arterial compliance) (AC = p(Ds  Ds  Dd 
Dd)/[4(Ps  Pd)]) where Ps and Pd are systolic and diastolic blood
pressure in the brachial artery measured by an automated
sphygmomanometer (Omron 705CP, Tokyo, Japan), and Ds and
Dd are the maximal and minimal diameters of the right common
carotid artery measured by e-tracking (ultrasonic high resolution
wall tracking Aloka 10, Tokyo, Japan; 7.5 MHz linear array probe).
Adjustable gates were positioned at the junctions of the intima and
media, and diameter was calculated and displayed in real time as the
difference between the displacement waveforms of the anterior and
posterior walls. Measurements were taken as a mean of ﬁve beats; b
was log transformed for analyses, because its distribution was skew.
Arterial stiffness was automatically assessed at the common carotid
artery 2 cm before the bifurcation by Echo-tracking software
(ALOKA Prosound alpha 10 ultrasound machine, Mitakashi, Tokyo,
Japan). Echo-tracking system implemented in the ultrasound
machine allows accurate measurements of carotid diameter
changes, based on radio frequencies (RF) signals, able to detect
variations of the arterial diameters with a strictness of 0  01 mm.
Arterial pressure waveforms were derived noninvasively by echo
tracking from change in carotid diameter over time, and calibrated
using SBP and DBP (the software used needs to insert SBP and DBP
values in the system of the machine for the calibration). Two sliders
(tracking gates) were positioned on a 2D ultrasound image of the
common carotid artery, at the front and back walls of the adventitia of
the vessel. All acquisitions were synchronized with the electrocar-
diographic (ECG) signal. The main indices of arterial stiffness b-index,
arterial compliance (AC), AIx, local PWV, and Young elastic modulus
(Ep) were automatically calculated, as a mean of ﬁve beats, according to
established formulas. Regarding the AIx (Augmentation Index), it must
be noted that the arterial pressure waveform is a composite of the
forward pressure wave created by ventricular contraction and a
reﬂected wave. Waves are reﬂected from the periphery, mainly at
branch points or sites of impedance mismatch. In elastic vessels,
reﬂected wave tends to arrive back at the aortic root during diastole. In
presence of stiff arteries, the reﬂected wave arrives back at the central
arteries earlier, adding to the forward wave and augmenting the
systolic pressure. This phenomenon can be quantiﬁed through the
Augmentation Index (AIx) deﬁned as the difference between the second
and ﬁrst systolic peaks expressed as a percentage of the pulse pressure.9
Arterial compliance (AC) is deﬁned as the change in arterial
blood volume for a given change in arterial blood pressure (BP). By
simultaneously measuring the diameter of a blood vessel and the
Table 1
Clinical data of patients, including blood pressure values, body mass index, lipid
proﬁle, and main vascular parameters, from the group treated with ketogenic diet
and controls.
Ketogenic diet Control group p
(n = 23) (n = 20)
Age (years) at evaluation 11  8 10  7 0.67
Diet duration (months) 24  29 0
Systolic BP (mmHg) 105  10 103  8 0.48
Diastolic BP (mmHg) 55  5 53  6 0.2
Pulse pressure 60  4 59  5 0.47
Body mass index (kg/m2) 20  2 21  3
Total cholesterol (mg/dl) 224  88 175  55 0.038
Tryglycerides (mg/dl) 267  329 115  25 0.046
Glucose (mg/dl) 70  15 69  18
AIx (%) 3  2 8  3 0.001
B-index 5  0.7 3  0.5 0.001
IMT (mm) 0.43  0.08 0.40  0.05 0.1
Legend: BP, blood pressure; AIx and b index, arterial stiffness parameters; IMT,
carotid intima thickness. Data are expressed as mean value  SD.
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can be measured using ultrasound or magnetic resonance imaging.
The so-called b-index is derived from a logarithmic transfor-
mation of the curvilinear relationship between pressure and
diameter, as measured using an oscillometer arm cuff and an
ultrasound probe. Beta-index is a clinical parameter in what is
supposed to be independent of blood pressure.
2.3. Echocardiography
The M-mode echocardiogram was performed by using 3.5 MHz
phased array, placed on the III–IV left intercostal space along the
parasternal line, with patients supine, in left lateral decubitus and
the head of the bed kept at 308. The end-diastolic measurements of
left ventricular internal dimension, left interventricular septum and
posterior wall thickness at the QRS peak were measured by using the
Penn convention. The left ventricular mass was calculated according
to the Devereux formula. Complete 2-dimensional echocardiograms
were obtained during normal respiration.
2.4. Diastolic function assessment
The pulsed Doppler sample volume was placed at the mitral
valve tips and 5–10 cardiac cycles were recorded from the apical
window at a velocity of 100 mm/s. The following parameters of left
ventricular diastolic function were determined: early diastolic (E)
and late atrial (A) peak velocities (m/s) and their ratio, and E-wave
deceleration time (ms). The Doppler tissue imaging (DTI) program
was set to the pulsed-wave Doppler mode. Filters were set to
exclude high frequency signals, and the Nyquist limit was adjusted
to a velocity range of 15–20 cm/s, gains were minimized to obtain a
clear tissue signal with minimal background noise. All DTI
recordings were obtained during normal respiration. A 5-mm
sample volume was placed at the apical 4-chamber view on the
lateral corner of the mitral annulus. The resulting velocities were
recorded for 5–10 cardiac cycles at a sweep speed of 100 mm/s. The
following measurements were determined as diastolic indexes:
myocardial early (Em) and atrial (Am) peak velocities (m/s) and
their ratio.10 All echocardiographic and ultrasonographic exam-
inations were recorded on videotape for later playback and
analysis and performed by the same experienced physician. For all
ultrasonographic examinations, we used the Aloka alfa-10 (Aloka
Co., Ltd, Tokyo, Japan) equipped with a variable-frequency phased-
array transducer and DTI capabilities.
2.5. Statistical analysis
Continuous variables are expressed as means  SD and discrete
variables as counts and percentages. All statistical analyses were
performed by using GB-STAT version 6.50 (Dynamic Microsystems,
Inc, Silver Spring, MD, USA). Differences between two groups were
assessed by using the Student’s t test for unpaired data. Comparison of
categorical data were made using Fisher’s exact test. Pearson
correlation coefﬁcient was calculated in order to investigate the
linear relationship between stiffness parameters and other variables.
Stepwise forward regression analysis was performed to assess which
factors independently inﬂuence stiffness parameters. Variables
selected for inclusion in the models were signiﬁcant at univariate
analysis. Signiﬁcance was set at p < 0.05. Kappa statistic was used to
assess inter- and intra-reader variability for echocardiographic and
ultrasonographic parameters.
3. Results
The initial data entry comprised 46 patients who fulﬁlled all the
inclusion criteria for enrollment; three patients were excludedfrom the study because of poor compliance to undergo all the
examinations requested by the study schedule.
The population study was consequently composed by 43
patients (23 males, 20 females), aged between 19 months and 31
years (mean 11 years, median 8 years and 4 months).
Patients not treated with ketogenic diet (20 pts) (control group):
All patients (9 males, mean age 10  7 years at the time of
evaluation) were affected by refractory epilepsy and epileptic
syndromes as follows: epileptic encephalopathy (11 pts), symptom-
atic West syndrome (3 pts), severe myoclonic epilepsy in infancy (3
pts), partial epilepsy (3 pts). No patient had hypercholesterolemia and
hypertrygliceridemia.
Patients treated with ketogenic diet (23 pts):
All patients (11 males, mean age 11  8 years at the time of
evaluation) were affected by refractory epilepsy and epileptic
syndromes as follows: epileptic encephalopathy (13 pts), symptom-
atic West syndrome (2 pts), GLUT1 deﬁciency (1 pt), severe myoclonic
epilepsy in infancy (2 pts), partial epilepsy (5 pts). The age at diet
onset was comprised between 3 months and 17 years (mean 5 years
and 11 months; median 6 years and 1 months). The time interval
between the end of the ketogenic diet and follow-up ranged between
16 months and 6 years (mean 3 years; median 3 years and 2 month).
The ketogenic diet lasted from 6 months to 10 years and 7 months
(mean 2 years, median 15 month). Triglycerides during the ketogenic
diet were over the normal range in 17 patients, with mean value of
267  329 mg/dl (range 81–1403). Thirteen patients (74%) showed
both hypercholesterolemia and hypertriglyceridemia.
All but one with Glut-1 deﬁciency syndrome was taking
antiepileptic drugs in combination (mean 2–3 drugs). The drugs
most frequently prescribed in both groups were: valproic acid,
levetiracetam, topiramate, carbamazepine, phenobarbital, benzo-
diazepines, zonisamide, and clobazam.
Table 1 reports the demographic and clinical characteristics of
patients, from the group treated with ketogenic diet and controls
and shows a signiﬁcant difference in stiffness parameters and
cholesterol and triglycerides levels. Subjects treated with keto-
genic diet had higher AIx, b-index and levels of blood cholesterol or
triglycerides compared to those never treated with ketogenic diet
(p < 0.001). In these two groups there were no signiﬁcant
differences in fasting blood glucose, serum creatinine, systolic
and diastolic blood pressure, pulse pressure, and BMI. Patients
treated with KD showed a not signiﬁcantly increased carotid IMT
(p: n.s.). Moreover, there were not signiﬁcant differences in all
diastolic parameters (Table 2).
A weak positive correlation was found between b-index and
total cholesterol (p < 0.002), AIx and triglycerides (p < 0.003).
Table 3
Multivariate analysis.
Examined variable b t p
Independent variable
AIx Age 2.120624 1.8998 .0799
Total cholesterol .01646 .004489 .0016
Tryglycerides .017769 .9583 .003
b-index Age 1.8 1.786 .057
Total cholesterol .02231 .003345 .0021
Tryglycerides .015676 .8767 .0034
Legend: b standardized regression coefﬁcient, t nonparametric t-test for beta, p
value for signiﬁcance. AIx and b-index, arterial stiffness parameters.
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BMI, plasma glucose, total cholesterol, HDL cholesterol, triglycer-
ides and serum creatinine levels. Stepwise forward regression
analysis was performed with AIx and b-index as a dependent
variable and with age, systolic and diastolic blood pressure, pulse
pressure, carotid IMT, LVMI, E-wave deceleration time, E/A and Em/
Am ratios and total cholesterol and triglycerides as independent
variables. As shown in Table 3, total cholesterol and triglycerides
parameter were independently related to b-index and AIx. The
inter- and intra-reader variability was good (k > 0.73).
In order to ﬁnd a correlation between vascular parameters and
the length of time on KD, patients were divided into 2 subgroups:
group 1 (11 pts) (length  12 months; mean 7.73, median 9.0, SD
4.65), and group 2 (12 pts) (length > 12 months; mean 39.5, median
29.5, SD  32.26).
The comparison between each sub-group and the control group
showed a statistically signiﬁcant variation in group 1 concerning
the parameters AC (p = 0.004) and AIx (p = 0.002).
In order to ﬁnd a correlation between vascular parameters’
assessment and the time since discontinuation of the KD (free
interval), patients were divided into 2 subgroups: group A (10 pts)
(free interval 36 months; mean 16.20, median 20.0, SD 13.95),
and group B (13 pts) (free interval >36 months; mean 60.54, median
52.0, SD 22.51).
The comparison between each sub-group A and B and the
control group showed a statistically signiﬁcant variation in group A
concerning the parameter AIx (p = 0.02).
Age at follow-up, gender and concomitant antiepileptic drugs
were not signiﬁcantly correlated with changes of the arterial
stiffness parameters. In contrast, a signiﬁcant correlation between
b-stiffness and blood levels of total cholesterol was found (Fig. 1),
as well as a signiﬁcant correlation between AIx values and serum
triglycerides (p < 0.001) (Fig. 2).
4. Discussion
In the present study, we examined children and young adults
affected by drug resistant epilepsy treated with ketogenic diet for a
mean time period of two years and found that local and systemic
arterial stiffness was signiﬁcantly increased compared with a
matched control group, and related to serum cholesterol and
triglycerides levels.
This data was independent of age, arterial pressure, gender, and
anticonvulsant therapy. Furthermore, left ventricule’ relative
thickness and diastolic function were worse in patients treated
with ketogenic diet than controls.
Further, the echo-color Doppler study did not show any
macroscopic ﬁnding such as atheromasic plaques, abnormal
thickness and echogenicity of the common carotid artery.
Nonetheless, there was a signiﬁcant change of parameters relative
to the arterial stiffness, including b-index and Augmentation
Index. Of note is that these parameters are speciﬁc and sensitive ofTable 2
Comparison of echocardiographic indexes between patients and controls.
KD Not KD p
LVDD (cm) 4.33  0.55 4.41  0.44 n.s
LVDS (cm) 2.53  0.45 2.61  0.38
LVM index (g/m) (2.7) 36.5  10 33.3  5 0.2
RT 39  3 37  5 n.s
E/A ratio 2.1  0.3 2.2  0.4 n.s
LV ﬁlling pressure (E/E0) 9  3 8  2 n.s
E deceleration (ms) 133  23 129  25 n.s
IVRT (ms) 63  8 67  9 n.s
Legend: E, early diastolic; A, late atrial; LV, left ventricule; LVDS, left ventricule
diameter systole; LVDD, left ventricule diameter diastole; IVRT, isovolumic
relaxation time; LVM, left ventricular mass. Data are expressed as mean value  SD.early functional endothelial damage. Further, in patients with
over-the-range cholesterol and triglycerides, the AI index was
signiﬁcantly above the normal range, thus suggesting a potential
correlation with the endothelial damage.
Accordingly, in patients who have been taking the ketogenic
diet for longer periods, mild but signiﬁcant abnormal values of IM-
GSM (echogenicity of vessel wall), and b-index and AIx (arterial
stiffness), were found. As a result, our patients treated with KD
showed a signiﬁcant increase in arterial stiffness without any
change in carotid IMT, thus conﬁrming arterial stiffness as an early
marker of cardiovascular damage. So far, data coming from
literature on the relationship between ketogenic diet and
cardiovascular effects regards substantially the ischemic risk
and serum lipid changes. In addition, these studies performed in
animals and humans are somewhat controversial. More in detail,
Al-Zaid et al.,11 found that a low carbohydrate ketogenic diet
enhances the cardiac tolerance to global ischemia in rats with
global ischemic injury, thus suggesting that the low carbohydrate
ketogenic diet is functionally cardio-protective. On the contrary,
Oishi et al.,12 found that the ketogenic status in mice fed with the
ketogenic diet increases hypoﬁbrinolytic risk by inducing abnor-
mal circadian expression of plasminogen activator inhibitor-1.
Furthermore, Westman et al.,13 reported that a low carbohy-
drate ketogenic diet led to beneﬁcial changes in serum lipid
subclasses, consisting of a shift from small, dense LDL to large,
buoyant LDL, which could lower cardiovascular disease risk, during
weight loss in overweight, hyperlipidemic community adult
volunteers. Overlapping data were reported by Sharman et al.,14
in normal-weight men in whom a short-term KD favorably affected
serum biomarkers for cardiovascular disease.
More concerns are indeed expressed by Kwiterovich et al.,15
who found that the ketogenic diet produced signiﬁcant increases in
the atherogenic apoB-containing lipoproteins and a decrease in the
antiatherogenic HDL cholesterol.
The vascular changes found in the present study, have to be
evaluated in terms of beneﬁt/risk ratio, considering that childrenFig. 1. Relationship between b-index and serum total cholesterol level.
Fig. 2. Relationship between Augmentation Index (AIx) and serum triglycerides.
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epileptic encephalopathies or congenital metabolic disorders such
as GLUT-1 deﬁciency disorder,16 for which the diet is a ﬁrst-choice
therapy. Interestingly, predictive value of arterial stiffness is due to
structural changes of vessels walls that precede the appearance of
echographic lesions including carotid intima thickening and
plaques.17 Disclosing early changes in arterial stiffness may lead
to a potential prophylactic drug treatment, including, for instance,
ACE-inhibitors or calcium channel blockers.
On this subject, Dahlin et al.,18 reported the potential efﬁcacy of
an early supplementation of the diet with omega-3 fat acid, in the
aim of decreasing the omega 6/omega 3 ratio and, accordingly, the
cardiovascular risk.
Data show values of Augmentation Index signiﬁcantly higher in
subjects free from ketogenic diet for less than 3 years (mean value
1.4) versus subjects free from ketogenic diet for more than 3 years
(mean 5.5) and versus control group (mean 2.1).
Ketogenic diet is known to have effects on lipid metabolism,
increasing blood total cholesterol in at least a subset of patients.15
Hypercholesterolemia has effects on arterial walls, generating
early dysfunctions such as arterial stiffness. Our data suggest the
possibility that arterial stiffness may regress after more than 3
years free from ketogenic diet. Our hypothesis is that discontinua-
tion of ketogenic diet lowers cholesterol levels, and that a long
period of low-to-normal cholesterol can lead to regression of
arterial wall early dysfunctions in children and adults with no
other cerebrovascular risk factors. Recently Ferrier et al.19 have
demonstrated that intensive reduction of blood cholesterol values
can lead to lower arterial stiffness in patients affected by isolated
systolic hypertension. Improving the evidence of damage revers-
ibility on arterial walls may be useful in managing patients who
have great clinical beneﬁts from ketogenic diet, but tend to develop
early arterial walls alterations.
To the best of our knowledge, this is the ﬁrst study that
addressed endothelial function in patients fed the ketogenic diet.
However, there are some limitations to be taken into account: (1) it
is not a longitudinal study, but patients were compared with sex
and age matched control group; (2) the number of patients studied
is small, but a good adherence to the study protocol was difﬁcult to
obtain; (3) considering this as not an intrapatient longitudinal
study, we decided to rule out potential risk factors predisposing to
cardiovascular impairment (e.g. arterial hypertension, diabetes
mellitus). Although such patients are not excluded from the
ketogenic diet in clinical practice.
In conclusion, our data show that arterial stiffness is increased
in children and young adults with high level of cholesterol due to
the ketogenic diet, before the increase of the intima media
thickness. Arterial stiffness is therefore an early marker of vascular
damage and indicates risk for later arterial disease.
Furthermore, our study shows that the arterial mechanical
impairment, as measured by local b-index and systemic (AIx)stiffness indices, gets worse according to higher plasma cholesterol
levels. The ﬁnding of slight endothelial changes might justify an
early preventive treatment. In case of patients with increased lipid
proﬁle on the ketogenic diet, changes in diet regimen such as
shifting to a 4:1 to a 3:1 fat/protein plus carbohydrate ratio or
increasing polyinsature fat acids amount and/or adding omega-3
compounds, may be tried. In presence of very high lipid proﬁle,
ketogenic diet could be quickly withdrawn or alternative treat-
ments including low glycemic index diet or modiﬁed Atkins diet
might be considered. Indeed, cost/beneﬁt ratio should always
guide the clinical approach, even trying to decrease the overall
length of diet treatment. Only studies in larger cohorts of patients
fed with the ketogenic diet for longer periods, might better clarify
the actual impact of this alternative therapy on the endothelial
vascular function and its role on inﬂammation and development of
atherosclerotic lesions.
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